RCAN CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RCAN Gen Silencer sind erhältlich als RCAN CRISPR/Cas9 Knockout Plasmide und RCAN Double Nickase Plasmide. RCAN CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RCAN CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RCAN2 CRISPR/Cas9 KO Plasmid (h) | sc-417136 | h | Gene Knockout | GFP | 0 | ||
RCAN2 HDR Plasmid (h) | sc-417136-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RCAN2 Double Nickase Plasmid (h) | sc-417136-NIC | h | Gene Knockout | Puromycin | 0 | ||
RCAN2 Double Nickase Plasmid (h2) | sc-417136-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RCAN2 CRISPR/Cas9 KO Plasmid (m) | sc-424772 | m | Gene Knockout | GFP | 0 | ||
RCAN2 HDR Plasmid (m) | sc-424772-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RCAN2 Double Nickase Plasmid (m) | sc-424772-NIC | m | Gene Knockout | Puromycin | 0 | ||
RCAN2 Double Nickase Plasmid (m2) | sc-424772-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RCAN3 CRISPR/Cas9 KO Plasmid (h) | sc-416609 | h | Gene Knockout | GFP | 0 | ||
RCAN3 HDR Plasmid (h) | sc-416609-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RCAN3 Double Nickase Plasmid (h) | sc-416609-NIC | h | Gene Knockout | Puromycin | 0 | ||
RCAN3 Double Nickase Plasmid (h2) | sc-416609-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RCAN3 CRISPR/Cas9 KO Plasmid (m) | sc-424773 | m | Gene Knockout | GFP | 0 | ||
RCAN3 HDR Plasmid (m) | sc-424773-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RCAN3 Double Nickase Plasmid (m) | sc-424773-NIC | m | Gene Knockout | Puromycin | 0 | ||
RCAN3 Double Nickase Plasmid (m2) | sc-424773-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RCAN CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RCAN2 CRISPR Activation Plasmid (h) | sc-417136-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activation Plasmid (h2) | sc-417136-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (h) | sc-417136-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (h2) | sc-417136-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activation Plasmid (m) | sc-424772-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 CRISPR Activation Plasmid (m2) | sc-424772-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (m) | sc-424772-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN2 Lentiviral Activation Particles (m2) | sc-424772-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activation Plasmid (h) | sc-416609-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activation Plasmid (h2) | sc-416609-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (h) | sc-416609-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (h2) | sc-416609-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activation Plasmid (m) | sc-424773-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 CRISPR Activation Plasmid (m2) | sc-424773-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (m) | sc-424773-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RCAN3 Lentiviral Activation Particles (m2) | sc-424773-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |